kw.\*:("Ceftazidime")
Results 1 to 25 of 1381
Selection :
Microbiological assay for ceftazidime injectionDE HARO MORENO, Andréia; NUNES SALGADO, Hérida Regina.Journal of AOAC International. 2007, Vol 90, Num 5, pp 1379-1382, issn 1060-3271, 4 p.Article
Population pharmacokinetics of ceftazidime in burn patientsDAILLY, Eric; PANNIER, Michel; JOLLIET, Pascale et al.British journal of clinical pharmacology. 2003, Vol 56, Num 6, pp 629-634, issn 0306-5251, 6 p.Article
Rapid and Selective UV Spectrophotometric Method for the Analysis of CeftazidimeDE HARO MORENO, Andréia; NUNES SALGADO, Hérida Regina.Journal of AOAC International. 2009, Vol 92, Num 3, pp 820-823, issn 1060-3271, 4 p.Article
Development and Validation of an Agar Diffusion Assay for Determination of Ceftazidime in Pharmaceutical PreparationsSCHMIDT, Cleber A; CARAZZO, Marcelly; LAPORTA, Luciane V et al.Journal of AOAC International. 2008, Vol 91, Num 1, pp 59-66, issn 1060-3271, 8 p.Article
Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaineTHORNTON, Charles G; MACLELLAN, Kerry M; JR., Thomas L et al.Journal of microbiological methods. 2004, Vol 56, Num 2, pp 243-251, issn 0167-7012, 9 p.Article
Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysisKIMURA, Soichiro; ISHIGURO, Masaji; ISHII, Yoshikazu et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1454-1460, issn 0066-4804, 7 p.Article
Development of a New High-Performance Liquid Chromatographic Method for the Determination of CeftazidimeDE HARO MORENO, Andreia; NUNES SALGADO, Hérida Regina.Journal of AOAC International. 2008, Vol 91, Num 4, pp 739-743, issn 1060-3271, 5 p.Article
High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitutionCARTELLE, Monica; DEL MAR TOMAS, Maria; MOLINA, Francisca et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2308-2313, issn 0066-4804, 6 p.Article
Ceftazidim. IIMARGET, W; GABLER-SANDBERGER, E; TOLXDORFF-NEUTZLING, R et al.Infection. 1987, Vol 15, pp 143-219, issn 0300-8126, suppl. 4Serial Issue
A simple formula for individualising ceftazidime dosage administered by continuous infusion in patients with haematological malignanciesDAILLY, Eric; BRUN, Anne; KERGUERIS, Marie-France et al.International journal of antimicrobial agents. 2006, Vol 27, Num 6, pp 553-556, issn 0924-8579, 4 p.Article
Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion techniqueMONTANARI, Maria Pia; PICCOLI, Laura; MINGOIA, Marina et al.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 2, pp 157-160, issn 0732-8893, 4 p.Article
Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coliKARISIK, E; ELLINGTON, M. J; PIKE, R et al.Clinical microbiology and infection. 2006, Vol 12, Num 8, pp 803-806, issn 1198-743X, 4 p.Article
Proteomic tracking and analysis of a bacterial mixed cultureKLUGE, Sabine; HOFFMANN, Marcus; BENNDORF, Dirk et al.Proteomics (Weinheim. Print). 2012, Vol 12, Num 12, pp 1893-1901, issn 1615-9853, 9 p.Article
Cefepime versus ceftazidime : considerations for empirical use in critically ill patientsROBERTS, Jason A; WEBB, Steven A. R; LIPMAN, Jeffrey et al.International journal of antimicrobial agents. 2007, Vol 29, Num 2, pp 117-128, issn 0924-8579, 12 p.Article
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosaGIAMARELLOS-BOURBOULIS, Evangelos J; KENTEPOZIDIS, Nikolaos; ANTONOPOULOU, Anastasia et al.Diagnostic microbiology and infectious disease. 2005, Vol 51, Num 2, pp 113-117, issn 0732-8893, 5 p.Article
Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo SimulationsCONIL, Jean-Marie; GEORGES, Bernard; RAVAT, François et al.Clinical therapeutics. 2013, Vol 35, Num 10, pp 1603-1612, issn 0149-2918, 10 p.Article
Why monotherapy?WILLIAMS, Keith J.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, issn 0305-7453, i18-i20, SUP1Article
A population pharmacokinetic approach to ceftazidime use in burn patients : influence of glomerular filtration, gender and mechanical ventilationCONIL, Jean Marie; GEORGES, Bernard; LAVIT, Michel et al.British journal of clinical pharmacology. 2007, Vol 64, Num 1, pp 27-35, issn 0306-5251, 9 p.Article
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibutenPERILLI, M; SEGATORE, B; TAVIO, M et al.Journal of chemotherapy. 2007, Vol 19, Num 2, pp 123-126, issn 1120-009X, 4 p.Article
Sensitivity and specificity of various β-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum β-lactamasesBEDENIC, B; VRANES, J; MIHALJEVIC, Lj et al.Journal of chemotherapy. 2007, Vol 19, Num 2, pp 127-139, issn 1120-009X, 13 p.Article
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase -producing Escherichia coliCAO BIN; WANG HUI; ZHU RENYUAN et al.Diagnostic microbiology and infectious disease. 2006, Vol 56, Num 4, pp 351-357, issn 0732-8893, 7 p.Article
Antimicrobial resistance in Salmonella enterica serovar Dublin isolates from beef and dairy sourcesDAVIS, Margaret A; HANCOCK, Dale D; BESSER, Thomas E et al.Veterinary microbiology (Amsterdam). 2007, Vol 119, Num 2-4, pp 221-230, issn 0378-1135, 10 p.Article
Simulation des Selektionsdrucks der Antibiotika Ciprofloxacin und Ceftazidim in Oberflächengewässern mittels klassischer Methoden = Simulation of the selection pressure of the antibiotics ciprofloxacin and ceftazidim in surface waters by means of classic methodsWIETHAN, Jürgen; AL-AHMAD, Ali; HENNINGER, Almut et al.Vom Wasser. 2000, Vol 95, pp 107-118, issn 0083-6915Article
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumanniiHERITIER, C; POIREL, L; NORDMANN, P et al.Clinical microbiology and infection. 2006, Vol 12, Num 2, pp 123-130, issn 1198-743X, 8 p.Article
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals : report from the SENTRY Antimicrobial Surveillance Program (1998-2004)PFALLER, Michael A; SADER, Helio S; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2006, Vol 56, Num 1, pp 63-68, issn 0732-8893, 6 p.Article